100
Participants
Start Date
April 30, 2001
Study Completion Date
November 30, 2004
Intrathecal (injected into the spinal fluid) DepoCyt
Intrathecal methotrexate
Intrathecal cytarabine (also known as ara-C)
University of Pittsburgh Cancer Institute, Pittsburgh
Georgetown University Medical Center Hematology/Oncology, Washington D.C.
Bowman Gray School of Medicine/Comprehensive Cancer Center of Wake Forest University, Winston-Salem
Emory Clinic, Department of Neurosurgery, Atlanta
Mayo Clinic, Jacksonville, Jacksonville
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Vanderbilt University Medical Center, Nashville
Case Western Reserve University Hospital of Cleveland, Cleveland
Park Nicollet Institute, Oncology Research Program, Minneapolis
Loyola University Medical Center, Dept. of Hematology/Oncology, Maywood
Rush Cancer Institute, Chicago
University of Texas Health Science Center, San Antonio
University of Colorado Hospital, Anschutz Cancer Pavilion, Denver
University of Utah, Hunsman Cancer Institute, Salt Lake City
Barrow Neurological Institute, Phoenix
University of Southern California, Norris Cancer Center, Los Angeles
Alta Bates Comprehensive Cancer Center, Berkeley
Straub Clinic and Hospital, Honolulu
Virginia Mason Medical Center, Seattle
Beth Israel Deaconess Medical Center Dept. of Neurology, Boston
JFK Neuroscience Institute, Edison
CancerCare Manitoba, Winnipeg
Toronto Sunnybrook Regional Cancer Center, Toronto
Lead Sponsor
Pacira Pharmaceuticals, Inc
INDUSTRY